Cytokine profile in Egyptian hepatitis C virus genotype-4 in relation to liver disease progression
about
Dominating expression of negative regulatory factors downmodulates major histocompatibility complex Class-II expression on dendritic cells in chronic hepatitis C infectionTumor Necrosis Factor-α-308 G/A Polymorphisms and Risk of Hepatocellular Carcinoma: A Meta-AnalysisFrom hepatitis to hepatocellular carcinoma: a proposed model for cross-talk between inflammation and epigenetic mechanismsSerum levels of soluble Fas, soluble tumor necrosis factor-receptor II, interleukin-2 receptor and interleukin-8 as early predictors of hepatocellular carcinoma in Egyptian patients with hepatitis C virus genotype-4Antioxidant and immunomodulatory effects of Viusid in patients with chronic hepatitis C.Interleukin-6 is associated with noninvasive markers of liver fibrosis in HIV-infected patients with alcohol problemsRelationship between circulating interleukin-10 and histological features in patients with chronic C hepatitisOncogenic potential of hepatitis C virus proteinsApelin serum level in Egyptian patients with chronic hepatitis CMarkers of inflammation and fibrosis in alcoholic hepatitis and viral hepatitis CThe use of whey protein concentrate in management of chronic hepatitis C virus - a pilot study.Immune-Inflammatory and Metabolic Effects of High Dose Furosemide plus Hypertonic Saline Solution (HSS) Treatment in Cirrhotic Subjects with Refractory Ascites.Serum Cytokine of IL-10 and IL-12 in Chronic Liver Disease: The Immune and Inflammatory Response.Early detection of hepatocellular carcinoma co-occurring with hepatitis C virus infection: A mathematical modelSerum Levels of Interleukin-6 and Interleukin-10 as Biomarkers for Hepatocellular Carcinoma in Egyptian Patients.Dynamic interplay between CXCL levels in chronic hepatitis C patients treated by interferon.Application of network construction to estimate functional changes to insulin receptor substrates 1 and 2 in Huh7 cells following infection with the hepatitis C virusA Possible Role for TNF-α in Coordinating Inflammation and Angiogenesis in Chronic Liver Disease and Hepatocellular Carcinoma.Cyclophilin A as a New Therapeutic Target for Hepatitis C Virus-induced Hepatocellular CarcinomaHepatocellular Carcinoma: Tumorigenesis and Prediction Markers.Polymorphisms of α1-antitrypsin and Interleukin-6 genes and the progression of hepatic cirrhosis in patients with a hepatitis C virus infection.Influence of camel milk on the hepatitis C virus burden of infected patients.Diabetes and infections-hepatitis C: is there type 2 diabetes excess in hepatitis C infection?Expression of pro- and anti-inflammatory cytokines in relation to apoptotic genes in Egyptian liver disease patients associated with HCV-genotype-4.Lack of Any Relationship Between Circulating Autoantibodies and Interleukin–6 Levels in Egyptian Patients Infected with the Hepatitis C VirusRole of cytokine levels in assessment of prognosis and post-treatment outcome in hepatocellular carcinoma.Cellular immune response to infection by different genotypes of hepatitis C virus.Immunomodulators, sFas and Fas-L as potential noninvasive predictors of IFN treatment in patients with HCV genotype-4.
P2860
Q24658465-DD422DFA-F310-42FC-8FDB-034EB797F4EAQ26743425-8DEAA45F-BCD2-4DC0-AB83-08B1454249B6Q28383729-2E092B6D-82D5-4F45-A027-ADEAE7161E37Q33640766-B042D57A-69B9-431B-84A1-5AE5D8DADE21Q33894202-E19B3609-18E9-4FE6-BA02-EBA1C0A95746Q34677793-0ADA79CD-9CDC-48E0-88D3-050E8A78A2A8Q35165793-91C53744-00B9-459D-A00E-7D5BEA39C368Q35261292-F9B5F9FF-C682-48C5-9383-60571DAFC321Q35294979-5A9CB423-0F0C-4DA6-B612-25FA33D53553Q35810531-C6617EBF-944A-43C4-957E-41C1B1456D2AQ35817765-5021F164-2749-4EE2-A853-253ECB228DA5Q36219910-AAF225F6-E4E5-4A22-9AF1-495814BFCFE1Q36400837-B471231F-3897-4D60-91F9-061B2AAE2D63Q36815018-4880CC63-B994-4409-BFAC-78C309DEB9DFQ36961950-510B771C-F7D4-41CB-8F97-B472DAF2C1B8Q37000796-86AB1E33-741D-4197-8E24-E9B849BA2FA3Q37190820-46C73751-F255-44BD-BD54-D5A722FFD86EQ37197025-6D64BDDE-3E22-4241-9DA9-0FE85F6F9B37Q37297666-184F713F-29B6-4298-A7CE-62B3FF52B1E6Q37477526-984F951B-1049-432B-A48F-B318B49A0410Q37689986-E96F8A60-8160-4F45-A3D1-61936ABD90F6Q37734598-E7660E73-651E-420B-B257-C918BD9DEB3FQ38086739-70C7C125-9073-49E2-8D63-5247171D79DEQ39624018-7256BE62-343A-4228-B8BD-A397BA270653Q40391710-4FA77F19-5588-44F7-85AB-D7A3A4B12B63Q40707004-2A1B4CCA-EECB-4F7C-8F6A-641551C01C6FQ42181529-CC708526-22C2-4E85-AAA6-AB1F82258542Q43038570-AA7C3127-5EAB-44C9-A86A-E26A1ACF613F
P2860
Cytokine profile in Egyptian hepatitis C virus genotype-4 in relation to liver disease progression
description
2005 nî lūn-bûn
@nan
2005 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Cytokine profile in Egyptian h ...... n to liver disease progression
@ast
Cytokine profile in Egyptian h ...... n to liver disease progression
@en
type
label
Cytokine profile in Egyptian h ...... n to liver disease progression
@ast
Cytokine profile in Egyptian h ...... n to liver disease progression
@en
prefLabel
Cytokine profile in Egyptian h ...... n to liver disease progression
@ast
Cytokine profile in Egyptian h ...... n to liver disease progression
@en
P2093
P2860
P356
P1476
Cytokine profile in Egyptian h ...... n to liver disease progression
@en
P2093
Abdel-Rahman N Zekri
Ahmed Hassan
Amal M R El-Shehaby
Hanaa M Alam El-Din
Maha A Abu-Shady
Mohammed S El-Din Ashour
P2860
P304
P356
10.3748/WJG.V11.I42.6624
P407
P577
2005-11-01T00:00:00Z